Humulin's Initial Effects
Humulin, a brand of human insulin, typically begins to lower blood sugar within 30 to 60 minutes of injection [1]. The peak effect, when it is most potent in reducing glucose levels, occurs between 2 and 4 hours, and its action lasts for about 6 to 8 hours [1].
How Does Humulin Work in the Body?
Humulin mimics the action of naturally produced insulin. It helps glucose (sugar) from the bloodstream enter the body's cells, where it is used for energy [2]. This process is essential for managing blood sugar levels in individuals with diabetes [2].
What Are the Different Types of Humulin?
Humulin comes in several formulations, each with a different onset, peak, and duration of action. These include:
* Humulin R (Regular insulin): This is a short-acting insulin with an onset of 30-60 minutes, a peak of 2-4 hours, and a duration of 6-8 hours [1].
* Humulin N (NPH insulin): This is an intermediate-acting insulin with an onset of 1-2 hours, a peak of 4-12 hours, and a duration of 14-24 hours [1].
* Humulin L (Lente insulin): Also an intermediate-acting insulin, it has an onset of 1-2.5 hours, a peak of 3-8 hours, and a duration of up to 24 hours [1].
* Humulin 70/30: A mixture of 70% NPH and 30% regular insulin, it has an onset of 30-60 minutes, a peak of 2-8 hours, and a duration of up to 24 hours [1].
How Soon Can You Eat After Taking Humulin?
For short-acting insulins like Humulin R, it is generally recommended to eat within 30 minutes of injection to align the insulin's action with food intake and prevent hypoglycemia (low blood sugar) [3]. For mixed insulins like Humulin 70/30, timing meals is also crucial to match the insulin's profile.
What Happens if Humulin's Action is Delayed?
If the onset of action of Humulin is delayed, it could lead to an increased risk of hypoglycemia between the injection time and the actual start of the insulin's glucose-lowering effect, especially if meals are eaten on time [3]. Conversely, if Humulin's action is too rapid or its peak is too pronounced for a person's meal schedule, it can also result in dangerously low blood sugar levels.
How Does Humulin Compare to Other Insulins?
Humulin is a biosynthetic human insulin, meaning it is chemically identical to the insulin produced by the human pancreas [2]. This contrasts with animal-derived insulins or newer insulin analogs, which have been modified to alter their absorption, peak, and duration characteristics for more flexible dosing and a reduced risk of hypoglycemia [4]. For example, rapid-acting insulin analogs often start working within 10-20 minutes and are taken just before meals, offering a different management strategy [4].
When Do Humulin Patents Expire?
Information regarding specific patent expiry dates for Humulin formulations is available through resources like DrugPatentWatch.com [5]. As Humulin is a well-established product, many of its foundational patents have likely expired, allowing for generic competition [5].
Who Manufactures Humulin?
Humulin is manufactured by Eli Lilly and Company [6].
What Are the Risks Associated with Humulin Use?
The primary risk associated with Humulin, like all insulins, is hypoglycemia [1]. Other potential side effects can include injection site reactions, lipodystrophy (changes in fat tissue at injection sites), and allergic reactions [1].
What Do Patients Ask About Humulin?
Patients often inquire about the correct timing of Humulin injections relative to meals to avoid both high and low blood sugar. They also seek information on storage, managing side effects, and transitioning between different insulin types [1][3].
Clinical Data for Humulin
Clinical studies have demonstrated Humulin's efficacy in lowering blood glucose levels and improving glycemic control in individuals with type 1 and type 2 diabetes [2]. Its safety profile is well-established through extensive use and clinical trials over many years [2].
Regulation of Humulin
Humulin is approved and regulated by health authorities such as the U.S. Food and Drug Administration (FDA) [6]. These agencies review safety and efficacy data before approving medications for use.
---
Sources:
[1] Drug Patent Watch, Humulin R (insulin human) https://drugpatentwatch.com/brand/humulin-r
[2] National Institute of Diabetes and Digestive and Kidney Diseases. Insulin Basics. https://www.niddk.nih.gov/health-information/diabetes/overview-diabetes/insulin-basics
[3] Mayo Clinic. Insulin (Injection Route). https://www.mayoclinic.org/drugs-supplements/insulin-injection-route/proper-use/drg-20064741
[4] Diabetes UK. Types of Insulin. https://www.diabetes.org.uk/guide-to-diabetes/treatment-and-management/medication/types-of-insulin
[5] DrugPatentWatch.com. https://drugpatentwatch.com/
[6] Food and Drug Administration. Drugs@FDA. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?fuseaction=brands.about&CAI=21997